Anupam Paul

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Background Chronic progressive multisystem granulomatous disease is seen in 10–30% of patients with sarcoidosis and can result in end organ damage [1]. Corticosteroids are the mainstay of treatment with the addition of cytotoxic agents in severe cases. Some patients are refractory to such treatment and therefore management is a challenge. There is currently(More)
  • 1